Aims and scope
Hepatology, Medicine and Policy seeks to situate biomedical advances in hepatology within the broader political and social context that determines the ultimate impact of research in both resource-rich and resource-limited settings. It encourages submissions in the areas of health policy, health systems, economics, epidemiology, health services, implementation research and delivery science, ethics, human rights, social mediators of health outcomes, and basic and clinical science.
The journal emphasises the translation of evidence into action, in part by encouraging the authors of original research articles to present their findings in ways that are meaningful to policy-makers, advocates and community members. Supplementary articles such as commentaries and patient perspectives are commissioned to help make research findings more widely accessible.
Hepatology, Medicine and Policy fills a gap in the scientific literature by integrating biomedical and public health perspectives on how to reduce suffering and death from liver-related diseases. The journal aims to galvanise the global public health response by providing a forum for researchers, policy-makers, health service providers, members of affected communities and other stakeholders to collectively explore how the greatest health gains can be achieved at the local, national and global levels. Our approach reflects a health systems perspective on public health challenges, with health system “building blocks” such as financing, the health workforce and health information systems all recognised as important areas of inquiry alongside medical products, vaccines and technologies.
All articles published by Hepatology, Medicine and Policy are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Hepatology, Medicine and Policy you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Hepatology, Medicine and Policy therefore levies an article-processing charge of £1370.00/$2145.00/€1745.00 for each article accepted for publication.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
BioMed Central provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
We are working closely with relevant indexing services including PubMed Central and Web of Science (Thomson Reuters) to ensure that articles published in Hepatology, Medicine and Policy will be available in their databases when appropriate.
Hepatology, Medicine and Policy operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
Manuscripts will initially be screened by the Editor-in-Chief. Manuscripts deemed suitable for peer review will be reviewed by at least 2 external experts.
All manuscripts submitted to Hepatology, Medicine and Policy should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Hepatology, Medicine and Policy
Articles in Hepatology, Medicine and Policy should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Hepatol Med Policy [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Hepatol Med Policy 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.
Why publish your article in Hepatology, Medicine and Policy
Hepatology, Medicine and Policy's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Hepatology, Medicine and Policy offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Hepatology, Medicine and Policy gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Hepatology, Medicine and Policy are included in article alerts and regular email updates. Some may be highlighted on Hepatology, Medicine and Policy’s pages and on the BioMed Central homepage.
In addition, articles published in Hepatology, Medicine and Policy may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Hepatology, Medicine and Policy. A list of articles recently press-released by journals published by BioMed Central is available here.
As an author of an article published in Hepatology, Medicine and Policy you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.